Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inventia Life Science develops the RASTRUM™ family of high-throughput bioprinting platforms that enable researchers to rapidly generate complex, reproducible three-dimensional human tissue-like cell models. These advanced in vitro systems closely mimic real human biology and disease states—improving the predictive power of preclinical drug discovery and biomedical research. Their technology supports applications across cancer biology, immuno-oncology, hepatotoxicity/liver disease modeling, neurodegeneration studies using iPSCs, fibrosis/inflammation research with fibroblasts, and more. The company has seen adoption by leading global pharmaceutical companies for early-stage drug screening.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inventia Life Science.